Target intelligence / Profile preview

Katanin p80 subunit B-like 1 pseudogene 5 (KATNBL1P5)

Target: KATNBL1P5
Molecular classification: Other (Pseudogene)

Overview

Katanin p80 subunit B-like 1 pseudogene 5 (KATNBL1P5) is classified as a processed pseudogene, meaning it is a non-coding DNA sequence that closely resembles the protein-coding gene KATNBL1 but lacks the ability to encode a functional protein[2][7]. KATNBL1P5 is not considered a therapeutic target and is not known to function as an enzyme, transporter, receptor, or signaling molecule. There are currently no known drugs or therapeutic agents that interact with KATNBL1P5. Its only characterized biological association is through altered DNA methylation patterns observed in some disease models, such as macrophages infected with Leishmania[4][8]. Unlike its parental protein-coding gene KATNBL1, which participates in microtubule severing and cellular dynamics[1][3], KATNBL1P5 does not have known direct biological functions or disease roles, and its clinical relevance remains unclear.

Other names: katanin regulatory subunit B1 like 1 pseudogene 5KATNBL1P5

Biological functions

Other (As a pseudogene, KATNBL1P5 likely does not encode a functional protein; potential regulatory effects via non-coding RNA mechanisms are not established)

Disease associations

Other (No known direct disease roles; differential methylation noted in macrophages infected with Leishmania[4][8])

Beyond the preview

Go deeper on Katanin p80 subunit B-like 1 pseudogene 5 (KATNBL1P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Katanin p80 subunit B-like 1 pseudogene 5 (KATNBL1P5).

Explore the full profile